Using Vaccum Assisted Closure of Wound Instead of Primary Closure as Prophylactic Way Against Burst Abdomen

ConditionBurst Abdomen
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University

About this trial

A vacuum-assisted closure (VAC) device also known as negative pressure wound therapy (NPWT), is a medical treatment used to promote wound healing, it involves using a specialized device to apply negative pressure (suction) to a wound, which helps to accelerate the healing process.

Benefits :

Improved Healing: By removing excess fluid and reducing edema, the VAC device promotes faster wound healing and tissue repair.

Reduced Risk of Infection: The negative pressure helps to reduce bacterial load and create a more favorable environment for healing.

Enhanced Perfusion: The suction can improve blood flow to the wound area, aiding in the delivery of nutrients and oxygen essential for healing.

Granulation Tissue Formation: The therapy encourages the growth of new tissue (granulation tissue) which fills the wound and supports closure.

Overall, VAC therapy is a valuable tool in modern wound care, particularly for complex or difficult-to-heal wounds. If you or someone you know is considering or using this therapy, it's important to follow the guidance of healthcare professionals to maximize its effectiveness and manage any potential risks.

the study aim to evaluate patients , identify high risk ones , preparing to close wound of laparotomy with vaccum assisted device instead of primary closure with suturing till patient's general condition improve then delayed primary closure and comparing that to high risk patients who close wound primarily with suturing in terms of rate of burst abdomen …this is a randomized controlled trial

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

intraabdominal sepsis (wbc:>12000,HR>90,T>38,tachypnea and proven infection) Malnutrition including anaemia and hypoproteinemia Chronic diseases including diabetes and uremia Increased intra abdominal pressure including persistent coughing ,diffuse gaseous distention Smoking Previous abdominal surgery Old age Steroid use

Disqualifiers

Patients having elective surgery Absence of intra abdominal sepsis Negative exploration

Trial design

Design model

Parallel

Treatments tested in this trial

  • Vaccum assisted closure

    Procedure/Surgery

    close skin and SC tissue by vaccum device

  • primary wound closure

    Procedure/Surgery

    close skin and SC tissue by primary closure

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: group AExperimental treatment 1 intervention
Group B: group BExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of postoperative burst abdomen in both group

number of patients who will have burst abdomen after surgery

Time frame
1 month

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: